COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

Srikanth Muppidi¹, Jeffrey T Guptill², Saiju Jacob³, Yingkai Li², Maria E Farrugia⁴, Amanda C Guidon⁵, Jinny O Tavee⁶, Henry Kaminski⁷, James F Howard Jr⁸, Gary Cutter⁹, Heinz Wiendl¹⁰, Matthew B Maas⁶, Isabel Illa¹¹, Renato Mantegazza¹², Hiroyuki Murai¹³, Kimiaki Utsugisawa¹⁴, Richard J Nowak¹⁵; CARE-MG Study Group

Collaborators, Affiliations

Collaborators

CARE-MG Study Group:
Amanda C Guidon, Alok Tyagi, Ana Paula Sousa, Anthony A Amato, Ashwin Pinto, Bhaskar Roy, Caroline Carmichael, Dubravka Dodig, Georgina Burke, Gary R Cutter, Henry J Kaminski, Heinz Wiendl, Hiroyuki Murai, Ikjae Lee, Isabel Illa, Jeffrey Guptill, James F Howard Jr, James Caress, Jane Pritchard, Jinny O Tavee, John Vissing, Kamla Best, Kimiaki Utsugisawa, Mahtab Ramezani, Mathew Maas, Maria E Farrugia, Michael K Hehir, Michelle Kaku, Natalia Jiménez Esquivel, Paul Gallagher, Paul Maddison, Philip A Ambrose, Renato E Mantegazza, Richard J Nowak, Rocio Vazquez Do Campo, Saiju Jacob, Sami Saba, Shahriar Nafissi, Shannon Itoyama, Srikanth Muppidi, Stuart Viegas Viegas, Victoria Marshall, Yingkai Li Li

Affiliations

¹ Department of Neurology, Stanford Medical Center, Stanford, CA 94304, USA. Electronic address: muppidis@stanford.edu.
² Duke University School of Medicine, Duke University, Durham, NC, USA.
³ Department of Neurology and Institute of Immunology and Immunotherapy, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
⁴ Neurology Department, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK.
⁵ Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Harvard University, Boston, MA, USA.
⁶ The Ken and Ruth Davee Department of Neurology, Northwestern University, Chicago, IL, USA.
⁷ Department of Neurology, The George Washington University, Washington, DC, USA.
⁸ Department of Neurology, University of North Carolina, Chapel Hill, NC, USA.
⁹ Department of Biostatistics, School of Public Health, The University of Alabama at Birmingham, Birmingham, AL, USA.
¹⁰ Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
¹¹ Department of Neurology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.
¹² Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
¹³ Neuroimmunology and Neuromuscular Diseases Unit, International University of Health and Welfare, Narita, Japan.
¹⁴ Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan.
¹⁵ Yale University School of Medicine, Yale University, New Haven, CT, USA.

PMID: 33212055
PMCID: PMC7837033
DOI: 10.1016/S1474-4422(20)30413-0

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

Srikanth Muppidi et al. Lancet Neurol. 2020 Dec.

. 2020 Dec;19(12):970-971.

doi: 10.1016/S1474-4422(20)30413-0.

Authors

Collaborators

CARE-MG Study Group:
Amanda C Guidon, Alok Tyagi, Ana Paula Sousa, Anthony A Amato, Ashwin Pinto, Bhaskar Roy, Caroline Carmichael, Dubravka Dodig, Georgina Burke, Gary R Cutter, Henry J Kaminski, Heinz Wiendl, Hiroyuki Murai, Ikjae Lee, Isabel Illa, Jeffrey Guptill, James F Howard Jr, James Caress, Jane Pritchard, Jinny O Tavee, John Vissing, Kamla Best, Kimiaki Utsugisawa, Mahtab Ramezani, Mathew Maas, Maria E Farrugia, Michael K Hehir, Michelle Kaku, Natalia Jiménez Esquivel, Paul Gallagher, Paul Maddison, Philip A Ambrose, Renato E Mantegazza, Richard J Nowak, Rocio Vazquez Do Campo, Saiju Jacob, Sami Saba, Shahriar Nafissi, Shannon Itoyama, Srikanth Muppidi, Stuart Viegas Viegas, Victoria Marshall, Yingkai Li Li

Affiliations

¹ Department of Neurology, Stanford Medical Center, Stanford, CA 94304, USA. Electronic address: muppidis@stanford.edu.
² Duke University School of Medicine, Duke University, Durham, NC, USA.
³ Department of Neurology and Institute of Immunology and Immunotherapy, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
⁴ Neurology Department, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK.
⁵ Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Harvard University, Boston, MA, USA.
⁶ The Ken and Ruth Davee Department of Neurology, Northwestern University, Chicago, IL, USA.
⁷ Department of Neurology, The George Washington University, Washington, DC, USA.
⁸ Department of Neurology, University of North Carolina, Chapel Hill, NC, USA.
⁹ Department of Biostatistics, School of Public Health, The University of Alabama at Birmingham, Birmingham, AL, USA.
¹⁰ Department of Neurology with Institute of Translational Neurology, University of Münster, Münster, Germany.
¹¹ Department of Neurology, Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.
¹² Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.
¹³ Neuroimmunology and Neuromuscular Diseases Unit, International University of Health and Welfare, Narita, Japan.
¹⁴ Department of Neurology, Hanamaki General Hospital, Hanamaki, Japan.
¹⁵ Yale University School of Medicine, Yale University, New Haven, CT, USA.

PMID: 33212055
PMCID: PMC7837033
DOI: 10.1016/S1474-4422(20)30413-0

No abstract available

PubMed Disclaimer

References

1. Korsukewitz C, Reddel SW, Bar-Or A, Wiendl H. Neurological immunotherapy in the era of COVID-19—looking for consensus in the literature. Nat Rev Neurol. 2020;16:493–505. - PMC - PubMed
1. Robberecht W, Bednarik J, Bourgeois P, Van Hees J, Carton H. Myasthenic syndrome caused by direct effect of chloroquine on neuromuscular junction. Arch Neurol. 1989;46:464–468. - PubMed
1. Cadisch R, Streit E, Hartmann K. Exacerbation of pseudoparalytic myasthenia gravis following azithromycin (Zithromax) Schweiz Med Wochenschr. 1996;126:308–310. (in German). - PubMed
1. Jacob S, Muppidi S, Guidon A. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci. 2020;412 - PMC - PubMed
1. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239–1242. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

Collaborators

Affiliations

COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)

Authors

Collaborators

Affiliations

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Medical